| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Contineum Therapeutics, Inc. | Director | Stock Option (right to buy) | 14.8K | Jun 26, 2025 | Direct | ||
| Artiva Biotherapeutics, Inc. | Director | Director Stock Option (Right to Buy) | 13.8K | Jun 24, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CTNM | Contineum Therapeutics, Inc. | Jun 26, 2025 | 1 | $0 | 4 | Jun 26, 2025 | Director |
| ARTV | Artiva Biotherapeutics, Inc. | Jun 24, 2025 | 1 | $0 | 4 | Jun 26, 2025 | Director |
| CTNM | Contineum Therapeutics, Inc. | Mar 14, 2025 | 1 | $0 | 4 | Mar 17, 2025 | Director |
| CTNM | Contineum Therapeutics, Inc. | Mar 14, 2025 | 0 | $0 | 3 | Mar 17, 2025 | Director |
| ARTV | Artiva Biotherapeutics, Inc. | Jul 18, 2024 | 0 | $0 | 3 | Jul 18, 2024 | Director |